Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    10924966 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
2 Recruiting Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection
Condition: Non-small Cell Lung Cancer
Interventions: Drug: consolidation chemotherapy of pemetrexed/docetaxel;   Radiation: split-course chest radiation;   Drug: concurrent chemotherapy
3 Recruiting Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: consolidation chemotherapy of pemetrexed or docetaxel after CCRT;   Radiation: chest radiation;   Drug: weekly DP concurrent with chest radiation
4 Terminated Photon/Proton Radiation Therapy for Oropharyngeal Cancers
Condition: Oropharyngeal Cancers
Intervention:
5 Completed Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Procedure: conventional surgery;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy;   Radiation: radiation therapy
6 Completed
Has Results
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
Condition: Cancer
Interventions: Drug: celecoxib;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiation Therapy

Study has passed its completion date and status has not been verified in more than two years.